These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 19918170)

  • 1. Pharmacokinetic disposition of sulfadoxine in children with acute uncomplicated falciparum malaria treated with sulfadoxine-pyrimethamine in South West Nigeria.
    Gbotosho GO; Happi CT; Sijuade A; Sowunmi A; Oduola A
    Am J Ther; 2012 Sep; 19(5):338-45. PubMed ID: 19918170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children.
    Sowunmi A; Fehintola FA; Adedeji AA; Gbotosho GO; Tambo E; Fateye BA; Happi TC; Oduola AM
    Trop Med Int Health; 2005 Nov; 10(11):1161-70. PubMed ID: 16262741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetics of sulfadoxine and pyrimethamine in Malawian children with malaria.
    Bell DJ; Nyirongo SK; Mukaka M; Molyneux ME; Winstanley PA; Ward SA
    Clin Pharmacol Ther; 2011 Feb; 89(2):268-75. PubMed ID: 21191379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulfadoxine-pyrimethamine pharmacokinetics in malaria: pediatric dosing implications.
    Barnes KI; Little F; Smith PJ; Evans A; Watkins WM; White NJ
    Clin Pharmacol Ther; 2006 Dec; 80(6):582-96. PubMed ID: 17178260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between the pharmacokinetics and in vivo therapeutic efficacy of sulfadoxine-pyrimethamine in Malawian children.
    Dzinjalamala FK; Macheso A; Kublin JG; Taylor TE; Barnes KI; Molyneux ME; Plowe CV; Smith PJ
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3601-6. PubMed ID: 16127028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic.
    Mayxay M; Khanthavong M; Lindegårdh N; Keola S; Barends M; Pongvongsa T; Yapom R; Annerberg A; Phompida S; Phetsouvanh R; White NJ; Newton PN
    Clin Infect Dis; 2004 Oct; 39(8):1139-47. PubMed ID: 15486837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of the failure of treatment with pyrimethamine-sulfadoxine in children with uncomplicated falciparum malaria.
    Sowunmi A; Fateye BA; Adedeji AA; Gbotosho GO; Happi TC; Bamgboye AE; Bolaji OM; Oduola AM
    Acta Trop; 2006 Apr; 98(1):6-14. PubMed ID: 16513078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics of pyrimethamine and sulfadoxine in children with congenital toxoplasmosis.
    Trenque T; Simon N; Villena I; Chemla C; Quereux C; Leroux B; Jaussaud R; Rémy G; Dupouy D; Millart H; Pinon JM; Urien S
    Br J Clin Pharmacol; 2004 Jun; 57(6):735-41. PubMed ID: 15151519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine-pyrimethamine resistance in malaria-infected patients from Nigeria.
    Happi CT; Gbotosho GO; Folarin OA; Akinboye DO; Yusuf BO; Ebong OO; Sowunmi A; Kyle DE; Milhous W; Wirth DF; Oduola AM
    Acta Trop; 2005 Sep; 95(3):183-93. PubMed ID: 16023986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of impact of artesunate on the disposition kinetics of sulfadoxine/pyrimethamine when the two drugs are concomitantly administered.
    Minzi OM; Gupta A; Haule AF; Kagashe GA; Massele AY; Gustafsson LL
    Eur J Clin Pharmacol; 2007 May; 63(5):457-62. PubMed ID: 17333157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic efficacy of sulfadoxine-pyrimethamine, amodiaquine and the sulfadoxine-pyrimethamine-amodiaquine combination against uncomplicated Plasmodium falciparum malaria in young children in Cameroon.
    Basco LK; Same-Ekobo A; Ngane VF; Ndounga M; Metoh T; Ringwald P; Soula G
    Bull World Health Organ; 2002; 80(7):538-45. PubMed ID: 12163917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of chloroquine, sulfadoxine/pyrimethamine, mefloquine and mefloquine-artesunate for the treatment of falciparum malaria in Kachin State, North Myanmar.
    Smithuis F; Shahmanesh M; Kyaw MK; Savran O; Lwin S; White NJ
    Trop Med Int Health; 2004 Nov; 9(11):1184-90. PubMed ID: 15548314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics of pyrimethamine and sulfadoxine in children treated for congenital toxoplasmosis.
    Corvaisier S; Charpiat B; Mounier C; Wallon M; Leboucher G; Al Kurdi M; Chaulet JF; Peyron F
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3794-800. PubMed ID: 15388436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics of chloroquine and sulfadoxine and treatment response in children with malaria: suggestions for an improved dose regimen.
    Obua C; Hellgren U; Ntale M; Gustafsson LL; Ogwal-Okeng JW; Gordi T; Jerling M
    Br J Clin Pharmacol; 2008 Apr; 65(4):493-501. PubMed ID: 18294337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Open randomized study of pyrimethamine-sulphadoxine vs. pyrimethamine-sulphadoxine plus probenecid for the treatment of uncomplicated Plasmodium falciparum malaria in children.
    Sowunmi A; Fehintola FA; Adedeji AA; Gbotosho GO; Falade CO; Tambo E; Fateye BA; Happi TC; Oduola AM
    Trop Med Int Health; 2004 May; 9(5):606-14. PubMed ID: 15117306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population Pharmacokinetic Properties of Sulfadoxine and Pyrimethamine: a Pooled Analysis To Inform Optimal Dosing in African Children with Uncomplicated Malaria.
    de Kock M; Tarning J; Workman L; Allen EN; Tekete MM; Djimde AA; Bell DJ; Ward SA; Barnes KI; Denti P
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29463542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased efficacy of sulfadoxine-pyrimethamine in the treatment of uncomplicated falciparum malaria among children with sickle cell trait in Western Kenya.
    Terlouw DJ; Aidoo MA; Udhayakumar V; Kolczak MS; Oloo AJ; Kager PA; Lal AA; Nahlen BL; Kuile FO
    J Infect Dis; 2002 Dec; 186(11):1661-8. PubMed ID: 12447744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
    Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Séré Y; Rosenthal PJ; Ouédraogo JB
    Clin Infect Dis; 2007 Dec; 45(11):1453-61. PubMed ID: 17990228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic properties of conventional and double-dose sulfadoxine-pyrimethamine given as intermittent preventive treatment in infancy.
    Salman S; Griffin S; Kose K; Pitus N; Winmai J; Moore B; Siba P; Ilett KF; Mueller I; Davis TM
    Antimicrob Agents Chemother; 2011 Apr; 55(4):1693-700. PubMed ID: 21282434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short report: comparison of chlorproguanil-dapsone with a combination of sulfadoxine-pyrimethamine and chloroquine in children with malaria in northcentral Nigeria.
    Ogunfowokan O; Dankyau M; Madaki AJ; Thacher TD
    Am J Trop Med Hyg; 2009 Feb; 80(2):199-201. PubMed ID: 19190213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.